Clinical Trials Browser

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Endometrial Neoplasms

NCT04741256 2025-12-02

Implementation of a Standardized Tracheostomy Education Discharge Protocol

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT06804850 2025-11-19

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Phase 2 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT05954676 2025-10-28

Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT05754216 2025-10-01

Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms, Sleep Apnea, Obstructive

NCT05108233 2025-09-29

Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course

Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT01326468 2025-09-25

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT06276946 2025-09-05

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Xerostomia

NCT06347185 2025-07-17

SupCare

Phase NA Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT06513884 2025-06-22

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Phase 2/3 Withdrawn

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT01345084 2025-03-28

NICAP

Phase 3 Withdrawn

Head & Neck

Carcinoma, Head and Neck Neoplasms

Clinical Trials

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Implementation of a Standardized Tracheostomy Education Discharge Protocol

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery

Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve

Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

SupCare

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

NICAP